Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-05-10 Sale | 2019-05-14 9:00 pm | GW PHARMACEUTICALS PLC | GWPH | Gangolli Julian S President, North America | 671,928 | $14.84 | $9,973,283 | 117,151 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-07 Option Award | 2024-03-08 4:13 pm | N/A 2034-03-07 | Outlook Therapeutics Inc. | OTLK | Gangolli Julian S Director | 94,441 | $0 | 94,441 (Direct) | View |
| 2023-10-04 Option Award | 2023-10-06 08:16 am | N/A 2033-10-04 | Outlook Therapeutics Inc. | OTLK | Gangolli Julian S Director | 370,282 | $0 | 370,282 (Direct) | View |
| 2023-06-30 Option Award | 2023-07-03 4:16 pm | N/A 2033-06-30 | Krystal Biotech Inc. | KRYS | Gangolli Julian S Director | 6,800 | $0 | 6,800 (Direct) | View |
| 2023-05-03 Option Award | 2023-05-05 5:15 pm | N/A 2033-05-02 | Revance Therapeutics Inc. | RVNC | Gangolli Julian S Director | 9,449 | $0 | 36,021 (Direct) | View |
| 2023-03-29 Option Award | 2023-03-31 5:46 pm | N/A 2033-03-29 | Outlook Therapeutics Inc. | OTLK | Gangolli Julian S Director | 41,065 | $0 | 41,065 (Direct) | View |
| 2022-10-05 Option Award | 2022-10-07 4:36 pm | N/A 2032-10-05 | Outlook Therapeutics Inc. | OTLK | Gangolli Julian S Director | 74,398 | $0 | 74,398 (Direct) | View |
| 2022-06-30 Option Award | 2022-07-01 4:05 pm | N/A 2032-06-30 | Krystal Biotech Inc. | KRYS | Gangolli Julian S Director | 6,800 | $0 | 6,800 (Direct) | View |
| 2022-05-04 Option Award(A) | 2022-05-13 6:14 pm | N/A 2032-05-03 | Revance Therapeutics Inc. | RVNC | Gangolli Julian S Director | 10,756 | $0 | 10,756 (Direct) | View |
| 2022-05-04 Option Award | 2022-05-06 6:18 pm | N/A 2032-05-03 | Revance Therapeutics Inc. | RVNC | Gangolli Julian S Director | 17,402 | $0 | 37,915 (Direct) | View |
| 2022-03-23 Option Award | 2022-03-24 5:42 pm | N/A 2032-03-23 | Outlook Therapeutics Inc. | OTLK | Gangolli Julian S Director | 21,878 | $0 | 21,878 (Direct) | View |
| 2021-10-05 Option Award | 2021-10-07 5:07 pm | N/A 2031-10-05 | Outlook Therapeutics Inc. | OTLK | Gangolli Julian S Director | 44,466 | $0 | 44,466 (Direct) | View |
| 2021-06-30 Option Award | 2021-07-02 11:33 am | N/A 2031-06-30 | Krystal Biotech Inc. | KRYS | Gangolli Julian S Director | 6,800 | $0 | 6,800 (Direct) | View |
| 2021-05-05 Option Award | 2021-05-07 7:06 pm | N/A 2031-05-04 | Revance Therapeutics Inc. | RVNC | Gangolli Julian S Director | 11,564 | $0 | 28,064 (Direct) | View |
| 2021-03-24 Option Award | 2021-03-26 6:09 pm | N/A 2031-03-24 | Outlook Therapeutics Inc. | OTLK | Gangolli Julian S Director | 20,873 | $0 | 20,873 (Direct) | View |
| 2020-10-05 Option Award | 2020-10-05 6:41 pm | N/A 2030-10-05 | Outlook Therapeutics Inc. | OTLK | Gangolli Julian S Director | 150,748 | $0.5141 | 150,748 (Direct) | View |
| 2020-06-30 Option Award | 2020-08-07 8:22 pm | N/A 2030-06-29 | Krystal Biotech Inc. | KRYS | Gangolli Julian S Director | 6,800 | $0 | 6,800 (Direct) | View |
| 2020-07-17 Option Award | 2020-07-21 6:05 pm | N/A 2030-07-17 | Outlook Therapeutics Inc. | OTLK | Gangolli Julian S Director | 125,000 | $0 | 125,000 (Direct) | View |
| 2020-07-01 Option Award | 2020-07-06 8:40 pm | N/A 2030-07-01 | Outlook Therapeutics Inc. | OTLK | Gangolli Julian S Director | 35,006 | $0.9853 | 35,006 (Direct) | View |
| 2020-05-14 Option Award | 2020-05-15 6:33 pm | N/A 2030-05-13 | Revance Therapeutics Inc. | RVNC | Gangolli Julian S Director | 18,000 | $0 | 28,500 (Direct) | View |
| 2020-04-20 Option Award | 2020-04-21 6:39 pm | N/A 2030-04-20 | Outlook Therapeutics Inc. | OTLK | Gangolli Julian S Director | 25,000 | $0 | 25,000 (Direct) | View |
| 2019-05-10 Exercise | 2019-05-14 9:00 pm | N/A N/A | GW PHARMACEUTICALS PLC | GWPH | Gangolli Julian S President, North America | 403,804 | $0.0013 | 117,151 (Direct) | View |
| 2019-05-10 Exercise | 2019-05-14 9:00 pm | N/A N/A | GW PHARMACEUTICALS PLC | GWPH | Gangolli Julian S President, North America | 75,369 | $10.61 | 117,151 (Direct) | View |
| 2019-05-10 Exercise | 2019-05-14 9:00 pm | 2019-02-15 2020-03-15 | GW PHARMACEUTICALS PLC | GWPH | Gangolli Julian S President, North America | 671,928 | $0 | 117,151 (Direct) | View |
| 2019-05-10 Exercise | 2019-05-14 9:00 pm | N/A N/A | GW PHARMACEUTICALS PLC | GWPH | Gangolli Julian S President, North America | 192,755 | $3.72 | 117,151 (Direct) | View |
| 2019-05-09 Option Award | 2019-05-10 8:54 pm | N/A 2029-05-08 | Revance Therapeutics Inc. | RVNC | Gangolli Julian S Director | 13,500 | $0 | 19,500 (Direct) | View |